|
|
重组人血管内皮抑素联合放疗对肺腺癌A549细胞TGF-β1、HIF-1α表达的影响
|
Abstract:
| [1] | M. Kamrava, M. B. Bernstein, K. Camphausen, et al. Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: The three musketeers or just another quixotic combination? Molecular Biosystems, 2009, 5(11): 1262- 1270. |
| [2] | J. Folkman. Antiangiogenesis in cancer therapy—Endostatin and its mechanisms of action. Experimental Cell Research, 2006, 312(5): 594-607. |
| [3] | 林丽彬, 林建银. 内皮抑素及其抗血管生成作用[J]. 福建医科大学学报, 2007, 41(2): 189-190. |
| [4] | 王金万, 孙燕, 刘永煜等. 重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J]. 中国肺癌杂志, 2005, 8(4): 283-290. |
| [5] | Z. Y. You, Y. Zhao, F. Liu, et al. The radiosensitization effects of Endostar on human lung squamous cancer cells H-520. Cancer Cell International, 2010, 10: 17. |
| [6] | R. Feng, X. J. Huang. Preliminary study on the anti-leukemia effect of recombinant human endostatin. National Medical Journal of China, 2010, 31(7): 461-465. |
| [7] | Y. T. Jia, Z. X. Li, M. Liu, et al. Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer. National Medical Journal of China, 2009, 31(4): 254-257. |
| [8] | C. H. Heldin, M. Landstr？m and A. Moustakas. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial- mesenchymal transition. Current Opinion in Cell Biology, 2009, 21(2): 166-176. |
| [9] | S. Serratì, F. Margheri, M. Pucci, et al. TGF-beta1 antagonistic peptides inhibit TGF beta1-dependent angiogenesis. Biochemi-cal Pharmacology, 2009, 77(5): 813-825. |
| [10] | K. S. Chae, M. J. Kang, J. H. Lee, et al. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hy- poxic conditions. Oncogene, 2010 (Epub ahead of print). |
| [11] | L. Zhang, W. Ge, K. Hu, Y. Zhang, et al. Endostar down-regu- lates HIF-1 and VEGF expression and enhances the radiore-sponse to human lung adenocarcinoma cancer cells. Molecular Biology Reports, 2012, 39(1): 89-95. |
| [12] | G. L. Semenza. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene, 2010, 29(5): 625- 634. |
| [13] | S. Kitamura, Y. Maeshima, T. Sugaya, et al. Transforming growth factor-1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells. Nephron Experimental, 2003, 95: 79-86. |
| [14] | H. H. Lin, C. W. Tsai, F. P. Chou, et al. Andrographolide down- regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells. Toxicology and Applied Pharmacology, 2011, 250(3): 336-345. |
